Article Text

Download PDFPDF
Randomised controlled trial
The quadrivalent HPV vaccine is effective prophylaxis against HPV-related external genital lesions in young men

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests BD and AEG have received honoraria and research funding from CSL Biotherapies. BD has also received honoraria from Sanofi Pasteur MSD.